Literature DB >> 7641353

Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses.

C Chen1, L Li, L L Chen, J V Prada, M H Chen, J T Fallon, A E Weyman, D Waters, L Gillam.   

Abstract

BACKGROUND: Dobutamine stress echocardiography has been proposed as a diagnostic tool to identify viable myocardium. How regional wall thickening responds to dobutamine in the ischemic or short-term hibernating myocardium has not been adequately defined. We hypothesized that regional wall thickening would improve initially and subsequently deteriorate with incremental doses of dobutamine in viable myocardial regions supplied by a stenotic coronary artery. This study was undertaken to determine whether this biphasic pattern of regional function characterizes the response of ischemic or hibernating myocardium to dobutamine and to explore the factors and mechanisms that determine this response. METHODS AND
RESULTS: Twenty-six pigs in four groups were studied: a control group (n = 5) to assess the response of myocardium perfused by nonstenotic coronary artery to incremental doses of dobutamine, and three experimental groups with a left anterior descending coronary artery stenosis producing acute myocardial ischemia (n = 7), short-term myocardial hibernation for 90 minutes (n = 7), and short-term hibernation for 24 hours (n = 7) to determine the functional and metabolic response to dobutamine under these conditions. Regional coronary flow was reduced to 40% to 60% of baseline, with significant reductions of regional wall thickening as measured by two-dimensional echocardiography and sonomicrometers. An incremental dobutamine infusion from 2.5 to 25 micrograms.kg-1.min-1 increased wall thickening and coronary flow without lactate production in the control group. In the other three groups, during the incremental dobutamine infusion, regional wall thickening improved initially, from 11.4 +/- 7.5% to 19.8 +/- 11.4%, P < .01, at dobutamine doses of 2.5 to 10 (4.5 +/- 2.2) micrograms.min-1.kg-1 but deteriorated subsequently to 5.0 +/- 5.8% at the maximal dose of dobutamine of 12.6 +/- 4.1 micrograms.min-1.kg-1. The initial improvement of regional wall thickening was associated with a small increase in regional coronary flow (from 0.53 +/- 0.18 to 0.68 +/- 0.25 mL.min-1.g-1 myocardium, P < .05) and with regional lactate production. High doses of dobutamine did not further increase regional coronary flow but markedly increased lactate production and induced regional myocardial acidosis (pH 7.26 +/- 0.07). The biphasic pattern of response to dobutamine was observed in each of the three experimental groups. Both peak improvement and peak deterioration occurred earlier and at lower dobutamine dose levels in the group with acute ischemia compared with the group with short-term hibernation for 24 hours (P < .05).
CONCLUSIONS: A biphasic response of wall thickening to incremental dobutamine with initial improvement and subsequent deterioration is characteristic of ischemic or short-term hibernating myocardium. The initial low-dose dobutamine infusion improved wall thickening in the ischemic or hibernating myocardial region to a modest level. This initial modest improvement was transient and at the expense of metabolic deterioration of myocardial ischemia, so that at higher doses during prolonged dobutamine infusion, wall thickening deteriorated, lactate accumulated, and myocardial acidosis developed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641353     DOI: 10.1161/01.cir.92.4.756

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 3.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

4.  Stress radionuclide studies after acute myocardial infarction: changes with revascularization.

Authors:  I Coma-Canella; M del Val Gómez; L Salazar; F Gallardo
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

5.  Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing.

Authors:  Charaslak Charoenpanichkit; Timothy M Morgan; Craig A Hamilton; Eric L Wallace; Killian Robinson; William O Ntim; W Gregory Hundley
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-04       Impact factor: 7.792

6.  Low dose dobutamine echocardiography for predicting functional recovery after coronary revascularisation.

Authors:  F Piscione; P Perrone-Filardi; G De Luca; M Prastaro; C Indolfi; P Golino; S Dellegrottaglie; M Chiariello
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.

Authors:  D Pagano; R S Bonser; J N Townend; F Ordoubadi; R Lorenzoni; P G Camici
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

8.  Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease.

Authors:  Eric L Wallace; Timothy M Morgan; Thomas F Walsh; Erica Dall'Armellina; William Ntim; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

9.  Fluorodeoxyglucose uptake in dysfunctional myocardium subtended by an occluded coronary artery. Relation to dobutamine contractile reserve and Sestamibi uptake.

Authors:  K F Kofoed; S Carstensen; B Hesse; J D Hove; S Holm; M Jensen; S Haunsø; H Kelbaek
Journal:  Int J Card Imaging       Date:  1998-04

10.  Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study.

Authors:  Stephen G Sawada; Stephen Lewis; Roxanne Kovacs; Samer Khouri; Irmina Gradus-Pizlo; John A St Cyr; Harvey Feigenbaum
Journal:  Cardiovasc Ultrasound       Date:  2009-02-07       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.